Menu

Experience

Tom Coll

    • Arlo to Partner with Verisure 


    • Castle Biosciences $74 Million IPO 


    • Equillium – $65.4 Million IPO 


    • Dot Hill Systems sale to Seagate Technology 


    • Cooley Advises Xencor on its Initial Public Offering 


    • Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Flexion $74 Million Initial Public Offering 


    • Cooley Advised Flexion on Initial Public Offering 


    • Xencor Initial Public Offering 


    • Ambit Initial Public Offering 


    • Receptos, Inc. Initial Public Offering 


    • Cooley Advises Ambit on its IPO 


Contact us

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.